RNU6-467P

Across TCGA pan-cancer cohorts, RNU6-467P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU6-467P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RNU6-467P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-467P expression acts as an unfavorable survival marker, although some lineages such as OV and ESCA show a favorable association.

UVM, STAD, and OV are the cancer types where RNU6-467P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	II,III,IV	0.213	0.718	.002	81	view →
STAD	OS	Tertile	IV	0.052	0.496	<.001	36	view →
OV	DFS	Tertile	III,IV	0.701	0.365	.018	36	view →
SARC	DFS	Tertile	All	0.069	0.632	<.001	36	view →
KIRP	OS	Tertile	II,III,IV	0.178	0.743	.013	21	view →
KIRC	DFS	Tertile	All	0.155	0.627	.010	18	view →
GBM	OS	Tertile	All	0.005	0.416	<.001	18	view →
LUSC	DFS	Tertile	All	0.171	0.400	.033	18	view →
ESCA	OS	Tertile	II,III,IV	1.000	0.439	.017	12	view →
LGG	OS	Tertile	All	0.958	0.801	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU6-467P–UVM (OS)

Open the UVM breakdown →